➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Express Scripts
McKesson
Colorcon
Medtronic

Last Updated: June 5, 2020

DrugPatentWatch Database Preview

Interferon alfa-2b - Biologic Drug Details


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for interferon alfa-2b

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Edwin HorwitzPhase 1
Sabine Mueller, MD, PhDPhase 1
Pacific Pediatric Neuro-Oncology ConsortiumPhase 1

See all interferon alfa-2b clinical trials

Recent Litigation for interferon alfa-2b

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
Bay State Milling Company v. Arcadia Biosciences, Inc.2019-04-01
Novartis Vaccines and Diagnostics, Inc. v. Regeneron Pharmaceuticals, Inc.2018-03-19
Boston Heart Diagnostics Corporation v. MD Labs, Inc.2018-01-05

See all interferon alfa-2b litigation

PTAB Litigation
PetitionerDate
Regeneron Pharmaceuticals, Inc.2019-09-20
Regeneron Pharmaceuticals, Inc.2019-05-14
Baylor College of Medicine2018-04-18

See all interferon alfa-2b litigation

Pharmacology for interferon alfa-2b

Company Disclosures: US Patents for interferon alfa-2b

These patents were extracted from company disclosures
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Schering Corporation (Madison, NJ) 2002-11-19 RX company
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Biogen N.V. (Curacao, AN) 2002-07-23 RX company
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Schering Corporation (Kenilworth, NJ) 2039-03-29 RX company
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Schering Corporation (Kenilworth, NJ) 2014-10-11 RX company
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Hoffman-La Roche Inc. (Nutley, NJ) Genentech, Inc. (South San Francisco, CA) 2020-08-26 RX company
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Patent Text Search: US Patents for interferon alfa-2b

These patents were identified by searching patent claims

Supplementary Protection Certificates for interferon alfa-2b

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0137 Netherlands   Start Trial 300137, 20051030, EXPIRES: 20101029
049 Luxembourg   Start Trial 91049, EXPIRES: 20101030
2010 00005 Denmark   Start Trial PRODUCT NAME: CORIFOLLITROPIN ALFA
2010901806069 Italy   Start Trial AUTHORISATION NUMBER(S) AND DATE(S): EU/1/09/609/001-002, 20100125
C0004 France   Start Trial PRODUCT NAME: HORMONE FOLLICULO-STIMULANTE COMPRENANT UNE EXTENSION CTP, NOTAMMENT LA CORIFOLLITROPINE ALPHA; REGISTRATION NO/DATE IN FRANCE: EU/1/09/609/001 DU 20100125; REGISTRATION NO/DATE AT EEC: EU/1/09/609/001 DU 20100125
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
Medtronic
Colorcon
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.